(Q40515050)

21 September 2017

Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer (English)

1 reference

21 September 2017

1 reference

Yang WQ

1

1 reference

21 September 2017

Senger DL

2

1 reference

21 September 2017

Lun XQ

3

1 reference

21 September 2017

Muzik H

4

1 reference

21 September 2017

Shi ZQ

5

1 reference

21 September 2017

Dyck RH

6

1 reference

21 September 2017

Norman K

7

1 reference

21 September 2017

Brasher PM

8

1 reference

21 September 2017

Rewcastle NB

9

1 reference

21 September 2017

George D

10

1 reference

21 September 2017

Stewart D

11

1 reference

21 September 2017

Lee PW

12

1 reference

21 September 2017

Forsyth PA

13

1 reference

21 September 2017

1 November 2004

1 reference

21 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Gene Therapy

1 reference

21 September 2017

11

1 reference

21 September 2017

1579-1589

1 reference

21 September 2017

21

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302319

21 September 2017

0 references

cites work

Central nervous system metastasis from breast carcinoma. Autopsy study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Patterns of metastasis and natural courses of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Brain metastases in breast cancer; natural history, prognostic factors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

The alpha-anomeric form of sialic acid is the minimal receptor determinant recognized by reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Junction adhesion molecule is a receptor for reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus oncolysis of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus as an oncolytic agent against experimental human malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus therapy of lymphoid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Quantitative effects of cerebral infarction on spatial learning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Comparisons between C57BL/6J and A/J mice in motor activity and coordination, hole-poking, and spatial learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Place navigation impaired in rats with hippocampal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced apoptosis is mediated by TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus binds to multiple plasma membrane proteins of mouse L fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302319

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference